|
Announcements SYSTAGENIX
WOUND MANAGEMENT, LTD. SELECTS CLINIVATION WORLDVIEW®. Global
leader in the development and commercialization of advanced and general wound
care products selects clinivation WorldView as their enterprise solution for on-demand
global regulatory intelligence.
Natick, MA, June 3, 2009 - clinivation, Inc. announced today Systagenix
Wound Management, Ltd. has selected the clinivation WorldView enterprise solution
for On-Demand Global Regulatory Intelligence. "Systagenix is the
leader in the development and distribution of products in the treatment of chronic
and surgical wounds and the control of bleeding. We are pleased that they have
chosen clinivation WorldView for comprehensive, authoritative, and up-to-date
global regulatory intelligence," said Richard Morroney, R.A.C., C.Q.A., clinivation's
Vice President, Global Market Clearance Solutions. About
clinivation WorldView On-Demand Global Regulatory Intelligence
Clinivation WorldView is the medical device and diagnostic industry's most comprehensive,
authoritative, and up-to-date enterprise solution for On-Demand Global Regulatory
Intelligence. Providing clear, step-by-step market clearance regulations, processes,
and guidance for >99% of the world markets, only clinivation WorldView delivers
tried-and-true intelligence from certified, practicing professionals with real-world
experience. About Systagenix Wound Management, Ltd.
Systagenix Wound Management is committed to providing innovative products and
services that provide breakthrough clinical and economic outcomes in the treatment
of chronic and surgical wounds and the control of bleeding. Systagenix Wound Management
offers a complete line of products to meet the wound care needs of health care
professionals. The company's longstanding commitment to skin and wound care began
with the development of the first ready-made, ready-to-use surgical dressing in
the mid-1880s and continues today with innovative skin and wound care products
provided by three separate business units. For more information, please visit www.systagenix.com.
About clinivation, Inc. Clinivation
is the leading provider of integrated solutions that enable global market clearance.
Guided by our singular vision - "Excellence in Market Clearance" - clinivation
accelerates the entire market clearance cycle to advance new worldwide revenue
and achieve new milestones of enterprise value. Used in over 1,000,000 product
registrations by more than 100 companies worldwide, clinivation's end-to-end technology
and services deliver on our vision by eliminating revenue traps from global market
clearance operations, increasing process velocity with on-demand regulatory intelligence,
automating clearance-driven business controls, simplifying content unification
into market clearance applications, aligning quality systems with global market
clearance priorities, streamlining clinical development with clearance-focused
trials, and enabling management with key performance indicators for continuous
improvement and effective governance. The world's leading medical device,
diagnostics, hospital supply, and dental supply companies select clinivation because
of our medtech industry focus and our unique, integrated solutions that seamlessly
adapt to existing business processes and enterprise infrastructure- without the
need to write custom code. Our core brands include the clinivation Global xi
market clearance platform, clinivation WorldView on-demand regulatory intelligence,
and clinivation Clinical Suite and clinivation Registry Suite electronic data
capture and clinical data management software. Founded in 1999, the company
is headquartered in Natick, Massachusetts, with regional offices in North America
and Asia. Visit clinivation online at www.clinivation.com For
further information: For more information on clinivation's
integrated solutions that enable global market clearance, please click
here or call us at 508.655.6560. |